Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
暂无分享，去创建一个
M. Malim | R. Sanders | M. V. van Gils | S. Neil | C. Graham | K. Doores | J. Edgeworth | K. Bisnauthsing | P. Brouwer | R. Batra | B. Merrick | J. Seow | L. McCoy | S. Pickering | R. Galão | G. Nebbia | G. Betancor | S. Douthwaite | S. Acors | N. Kouphou | Lorcan O'Connell | K. Steel | O. Hemmings | J. Luptak | A. Signell | H. Wilson | Geraldine O'Hara | R. Martinez Nunez | Mark Tan Kia Ik | E. Macmahon | A. Patel | Rocio Martinez Nunez | L. O'Connell